Innovate New York 2009
Tuesday, October 27, 2009
The Levin Institute
Presented by the New York Academy of Sciences, The Levin Institute and the Alfred P. Sloan Foundation
There is a disconnect between the large number of life scientists involved in research enterprises in New York, and the relative weakness of its biotechnology sector. Join this panel to examine:
- Why, despite significant assets in NYC’s biotechnology sector, does a relative weakness persist?
- How can NYC derive new business opportunities from its prestigious biomedical research community?
- How can NYC better leverage assets such as the East River Science Park?
Innovate New York:
This is the third event in the Innovate New York series of panel discussions that will explore why New York is not widely known as a hub of innovation, despite its acknowledged leadership in many fields. Examining the role of innovation across fields from finance to arts and culture, this series will convene leaders in science, technology, finance, and business with the public to discuss New York's strengths, opportunities and challenges.
Innovate New York sessions are held at the Levin Institute’s Global Classroom, a unique theater-in-the round venue, and moderated by Levin’s President, Garrick Utley, whose talent for evoking intense dialogue with both panelists and the audience will drive the discussions. Panelists will include Ken Davis, President and CEO of the Mount Sinai Medical Center; Jonathan Bowles, Director of the Center for an Urban Future; Donna Rounds, Director of Technology Development at the Hospital for Special Surgery; and René Bastón, Chief Business Officer of the New York Academy of Sciences.
Innovate New York is a partnership of The Levin Institute and the New York Academy of Sciences, and is sponsored by the Alfred P. Sloan Foundation.